Telisotuzumab vedotin monotherapy in patients with previously treated c-Met plus advanced non-small cell lung cancer

Basit Öğe Kaydı
dc.authoridMoiseenko, Fedor/0000-0003-2544-9042
dc.authoridBar, Jair/0000-0002-1224-3646
dc.authorwosidMoiseenko, Fedor/E-1775-2014
dc.authorwosidBar, Jair/AAS-5743-2021
dc.contributor.authorHorinouchi, Hidehito
dc.contributor.authorGoldman, J. W.
dc.contributor.authorMoiseenko, F.
dc.contributor.authorCicin, I.
dc.contributor.authorFilippova, E.
dc.contributor.authorBar, J.
dc.contributor.authorTomasini, P.
dc.date.accessioned2024-06-12T11:20:22Z
dc.date.available2024-06-12T11:20:22Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description19th Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO) -- FEB 17-19, 2022 -- Kyoto, JAPANen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipJapanese Soc Med Oncol,European Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2022.05.182
dc.identifier.endpageS502en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS502en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.05.182
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25580
dc.identifier.volume33en_US
dc.identifier.wosWOS:000834940400282en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleTelisotuzumab vedotin monotherapy in patients with previously treated c-Met plus advanced non-small cell lung canceren_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu